ONEMEDNET CORPORATION Deferred Tax Assets, Operating Loss Carryforwards
ONEMEDNET CORPORATION (ONMD) had Deferred Tax Assets, Operating Loss Carryforwards of $9.20 million as of 2025-12-31, per its S-1/A filed 2026-07-08.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-07-08
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.20M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $9.09M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $7.39M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $6.82M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.55M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $6.97M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $9.20M S-1/A · filed 2026-07-08 | |
| 2024-12-31 | $9.09M S-1/A · filed 2026-07-08 | |
| 2023-12-31 | $7.39M 10-K · filed 2025-04-15 | $6.82M 10-K · filed 2024-04-09 |
| 2022-12-31 | $6.55M 10-K/A · filed 2024-11-05 | $6.97M 10-Q · filed 2023-11-20 |
| 2021-12-31 | $5.60M 10-Q · filed 2023-11-20 | $31.89K 10-K · filed 2022-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |